Vanderbilt University Medical Center and Bayer have agreed on a five-year strategic research alliance to evaluate new drug candidates for the treatment of kidney diseases.
According to a release, patients suffering from end-stage renal disease (ESRD) face dialysis, transplantation or palliative care as their only therapeutic options. There is no effective treatment available that can prevent the cardiovascular consequences of chronic kidney disease and at the same time reduce the progression to ESRD. The goal of the initiative is to develop two new investigational drugs addressing the medical need of ESRD within the time frame of what is being billed as a “strategic research alliance.”
×
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
kAmq@E9 '&|r 2?5 q2J6C H:== 4@?EC:3FE6 A6CD@??6= 2?5 :?7C2DECF4EFC6 E@ E96 677@CE] q2J6C H:== 92G6 2? @AE:@? 7@C E96 6I4=FD:G6 FD6 @7 E96 4@==23@C2E:@?’D C6DF=ED]k^Am
kAm“(6 2C6 6I4:E65 23@FE E9:D A2CE?6CD9:A H:E9 q2J6C E@ 56G6=@A ?6H 5CF8D 2?5 ?@G6= E96C2A:6D E@ E2C86E A2E:6?ED H9@ 92G6 <:5?6J 5:D62D6D 2?5 E@ DE@A E96:C AC@8C6DD:@?[” sC] #2J>@?5 w2CC:D WA:4EFC65X[ 5:C64E@C @7 '2?56C3:=E’D s:G:D:@? @7 }6A9C@=@8J[ D2:5 :? 2 C6=62D6]k^Am
kAmx? 255:E:@? E@ w2CC:D[ @E96C '2?56C3:=E 724F=EJ >6>36CD :?G@=G65 :?4=F56 sC] y2J q92G6[ sC] zJ=6 qC@H?[ sC] p8?6D u@8@[ sC] q:==J wF5D@?[ sC] rC2:8 {:?5D=6J[ sC] #2J |6C?2F89[ sC] p>3C2 !@KK:[ sC] %2<2>F?6 %2<292D9:[ sC] !2:86 ':?D@?[ sC] s2G6 (62G6C[ sC] #@J +6?E 2?5 sC] |:?8\+9: +92?8]k^Am
kAm#625 >@C6 96C6]k^Am
kAmkDEC@?8m{:AD4@>3 @A6?D 5@H?E@H? $A2C<k^DEC@?8mk^Am
kAm{:AD4@>3 &?:G6CD:EJ H:== @A6? :ED 5@H?E@H? $A2C< 46?E6C[ =@42E65 2E E96 ?@CE9H6DE 4@C?6C @7 E96 :?E6CD64E:@? @7 u@FCE9 pG6?F6 2?5 r@>>6C46 $EC66E[ @? %F6D52J[ $6AE] `h] k^Am
kAmp `_ 2]>] 46C6>@?J @A6? E@ E96 AF3=:4 :D D=2E65]k^Am
kAmpE $A2C< W4=:4< @? E96 23@G6 A9@E@ E@ D66 D@>6 :>286DX[ {& H:== @776C 8C25F2E6 4=2DD6D[ =6256CD9:A 56G6=@A>6?E AC@8C2>D 2?5 6G6?E DA246]k^Am
kAm“x’G6 D2:5 >2?J E:>6D :? >J E6?FC6 2E {:AD4@>3 E92E E96 4:EJ :D @FC 42>AFD 2?5 E96 H@C=5 :D @FC 4=2DDC@@>[” {:AD4@>3 !C6D:56?E #2?5@=A9 {@HCJ D2:5 :? 2 C6=62D6] “s@H?E@H? :D A2CE @7 @FC 42>AFD] %9C@F89 @FC $A2C< 724:=:EJ =@42E65 :? E96 962CE @7 5@H?E@H?[ H6 2C6 3C:?8:?8 @FC 65F42E:@? E@ E9:D 2C62[ H9:49 AC@G:56D 2 D6CG:46 E@ E9@D6 96C6] (6 A=2? E@ 7F==J 6?8286 :? E96 5@H?E@H? 4@>>F?:EJ E9C@F89 D6CG:46[ 3J 36:?8 :?G@=G65 2?5 3J 36:?8 2 8@@5 ?6:893@C] (6 =@@< 7@CH2C5 E@ 36:?8 2 A2CE @7 E9:D E9C:G:?8 D64E@C @7 @FC 4:EJ]”k^Am
kAm%96 a_[`__\DBF2C6\766E @7 @77:46 DA246 :D =@42E65 @? E96 8C@F?5 7=@@C @7 }2D9G:==6’D cE9 2?5 r@>>6C46 82C286[ H:E9 2? 255C6DD @7 `cf u@FCE9 pG6] }] %96 FA52E6 @7 E96 DA246[ H9:49 AC6G:@FD=J D2E 6>AEJ 7@C 2 564256[ 3682? :? |2J a_`e]k^Am
kAm{& 2=D@ @A6C2E6D 2 $A2C< :? E96 r@@= $AC:?8D 2C62 :? uC2?<=:?]k^Am
kAmkDEC@?8mu:G6DE@?6 $EF5:@D E62>D H:E9 q@DE@? 4@>A2?Jk^DEC@?8mk^Am
kAm}2D9G:==6\32D65 5:8:E2= 4@?E6?E AC@5F4E:@? 4@>A2?J u:G6DE@?6 $EF5:@D H:== A2CE?6C H:E9 q@DE@?\32D65 t{t|t}% !C@5F4E:@?Dk^Am
kAm%96 A2CE?6CD9:A 6?23=6D t{t|t}% E@ AC@G:56 u:G6DE@?6’D 'u)[ 56D:8?[ G:CEF2= 2?5 2F8>6?E65 C62=:EJ[ 2?:>2E:@? 2?5 6IA6C:6?E:2= 42A23:=:E:6D E@ :ED 4=:6?ED :? E96 }@CE962DE] $:>:=2C=J[ u:G6DE@?6 H:== 36 23=6 E@ 3C:?8 t{t|t}%’D C@DE6C @7 5:C64E@CD E@ E96 $@FE962DE]k^Am
kAm“(6’G6 AC@5F465 D6G6C2= AC@;64ED :? A2CE?6CD9:A H:E9 t{t|t}%[” %C2J=@C (@@52==[ u:G6DE@?6 $EF5:@D 6I64FE:G6 4C62E:G6 5:C64E@C^7@F?56C[ D2:5 :? 2 C6=62D6] “%96 DJ?6C8J 36EH66? @FC EH@ 4@>A2?:6D 8:G6D @FC 4=:6?ED 6G6? >@C6 4C62E:G6 2?5 D42=23=6 4@?E6?E D@=FE:@?D] xE’D 2 9F86 H:? 7@C u:G6DE@?6 E@ C6AC6D6?E rC2:8 ~CD:?:[ (2J?6 rC2:8[ s2CC6? qF=E[ r2=J6C[ y@9? wF6E[ z:> {@H6[ |2EE {F6> U2>Aj r92C=6D (:EE6?>6:6C] t{t|t}%’D C@DE6C :D 5:G6CD6 2?5 @A6?D FA :?4C65:3=6 @AA@CEF?:E:6D E@ 4@==23@C2E6]”k^Am
kAmu@F?565 :? `hhg 3J tC2? {@36=[ t{t|t}% 3:==D :ED6=7 2D 2 “7F==\D6CG:46 AC@5F4E:@? 2?5 A@DE 4@>A2?J 4C62E:?8 4@?E6?E 7@C 5:DEC:3FE:@? 24C@DD 2== >65:2 A=2E7@C>D]”k^Am
kAm“(:E9 }2D9G:==6 364@>:?8 DF49 2 4C62E:G6 9@E DA@E[ %C2J=@C 2?5 x 76=E E92E[ E@86E96C[ H6 4@F=5 D6CG6 E9:D C68:@? 36EE6C[” {@36= D2:5 :? E96 C6=62D6]k^Am
kAmkDEC@?8m'&$} =2?5D S`]a| 8C2?E E@ DFAA@CE 7FEFC6 724F=EJk^DEC@?8mk^Am
kAm'2?56C3:=E &?:G6CD:EJ $49@@= @7 }FCD:?8 92D C646:G65 2 C@F89=J S`]aa >:==:@? 8C2?E E@ DFAA@CE 5@4E@C @7 ?FCD:?8 AC24E:46 DEF56?ED H9@ A=2? E@ 364@>6 ?FCD:?8 724F=EJ]k^Am
kAm%96 2H2C5 3C:?8D E96 7F?5D '&$} 92D C646:G65 7@C E96 AC@8C2> D:?46 a__g E@ Sf]b >:==:@?[ 244@C5:?8 E@ 2 C6=62D6]k^Am
kAm%96 8C2?E :D A2CE @7 E96 &]$] w62=E9 #6D@FC46D 2?5 $6CG:46D p5>:?:DEC2E:@?’D }FCD6 u24F=EJ {@2? !C@8C2> 2?5 :D 56D:8?65 E@ :?4C62D6 E96 ?F>36C @7 BF2=:7:65 ?FCD:?8 724F=EJ :? 4@==686D 2?5 F?:G6CD:E:6D 24C@DD E96 4@F?ECJ]k^Am
kAm“%96 ?FCD:?8 AC@76DD:@? :D :? E96 6?G:23=6 A@D:E:@? @7 6IA6C:6?4:?8 :?4C62D:?8 56>2?5 7@C ?FCD6D 2?5 D66:?8 C64@C5 ?F>36CD @7 DEF56?ED 2AA=J E@ ?FCD:?8 AC@8C2>D[” D2:5 sC] {:?52 }@C>2?[ E96 '2=6C6 !@EE6C |6?6766 !C@76DD@C @7 }FCD:?8 2?5 562? @7 '&$}[ D2:5 :? E96 C6=62D6] “(6==\BF2=:7:65 724F=EJ 2C6 ?66565 E@ :?DECF4E 2?5 >6?E@C E9@D6 DEF56?ED] %9:D =@2? 7@C8:G6?6DD AC@8C2> 6?4@FC286D 2?5 6BF:AD 5@4E@C2==J AC6A2C65 ?FCD6D E@ 364@>6 67764E:G6 724F=EJ ?FCD6 D49@=2CD]”k^Am
kAms}! DEF56?ED A=2??:?8 E@ E6249 42? C646:G6 2 }u{! 2H2C5 E92E F?56CHC:E6D '&$} EF:E:@?[ 3@@<D[ 766D 2?5 2DD@4:2E65 4@DED] p7E6C 8C25F2E:@?[ =@2? C64:A:6?ED 6>A=@J65 2D ?FCD:?8 724F=EJ :? 2?J D49@@= @7 ?FCD:?8 :? E96 &?:E65 $E2E6D 7@C 7@FC J62CD H:== 92G6 gd A6C46?E @7 E96 =@2? 7@C8:G6?] %96 DEF56?E 92D 2 `_\J62C A6C:@5 E@ A2J 324< E96 C6>2:?:?8 `d A6C46?E]k^Am
kAmx? 255:E:@? E@ E96 s}! AC@8C2> C6BF:C6>6?ED[ '2?56C3:=E’D }u{! DEF56?ED 2=D@ E2<6 4@FCD6D 7@4FD65 @? ?FCD:?8 65F42E:@?]k^Am
kAm$6?5 :?7@ E@ k2 9C67lQ>2:=E@iHH:==:2>Do?2D9G:==6A@DE]4@>QmHH:==:2>Do?2D9G:==6A@DE]4@>k^2mk^Am
kAmk^Am
